Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesBio Green Med Solution, Inc.

Bio Green Med Solution, Inc.

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
0.71 USD 0.04 ( 5.94%)
Last update at 2026-11-12T15:41:00Z
VOLUME
9932
Market Cap
6.54M

Momentum Score

…

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.71
Low
0.73
High
52 Week Price Range
0.73
Low
98.40
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Bio Green Med Solution, Inc. (NASDAQ: BGMS) is a publicly listed company, but readily available filings and corporate disclosures provide limited detail on its core operations and product portfolio. Because long-term growth drivers are not well documented, investors should monitor future filings for verifiable revenue streams, regulatory milestones, or clear commercialization plans that could support valuation.
Primary investment risks include limited transparency and financial disclosure, minimal operating history or revenues, low liquidity and high share‑price volatility, and material regulatory or execution uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.67
Dividend Yield
-
Revenue TTM
0.75M
Revenue Per Share
0.34
Gross Profit TTM
-0.67M
Debt / Equity
0.00
ROE
-128.45%
Net Debt
-3.50M
ROCE
-122.97%
Diluted EPS TTM
-6.45

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.99M -11.99M -25.55M -25.91M -22.18M
Net income -3.00M -11.21M -22.55M -21.20M -18.46M
Selling general administrative 7.72M 5.39M 6.72M 7.38M 7.46M
Gross profit 0.14M 0.04M 0.42M -0.03M -0.04M
Reconciled depreciation 0.01M 0.01M 0.03M 0.03M 0.04M
Ebit -8.43M -12.00M -25.45M -27.66M -22.39M
Ebitda -8.42M -12.00M -25.42M -27.62M -22.35M
Depreciation and amortization 0.01M 0.01M 0.03M 0.03M 0.04M
Operating income -8.43M -12.00M -25.45M -27.66M -22.39M
Other operating expenses 9.17M 12.05M 25.87M 27.66M 22.39M
Tax provision 0.01M -0.78M -3.00M -4.72M -3.73M
Interest income 0.06M 0.01M 0.27M 0.21M 0.02M
Net interest income 0.06M 0.01M 0.27M 0.21M 0.02M
Income tax expense 0.01M -0.78M -3.00M -4.72M -3.73M
Total revenue 0.75M 0.04M 0.42M 0.00M 0.00M
Total operating expenses 8.56M 12.05M 25.87M 27.66M 22.39M
Cost of revenue 0.61M 0.00M - 0.03M 0.04M
Total other income expense net 5.44M 0.01M -0.10M 1.74M 0.20M
Net income from continuing ops -3.00M -11.21M -22.55M -21.20M -18.46M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 8.19M 4.09M 8.80M 28.05M 43.14M
Other current assets 0.11M 0.30M 0.34M 0.43M 0.08M
Total liab 1.34M 6.27M 8.20M 7.62M 5.44M
Total stockholder equity 6.84M -2.17M 0.61M 20.43M 37.69M
Other current liab 0.71M 1.67M 4.62M 4.95M 3.30M
Common stock 0.01M 0.01M 0.00M 4.50M 0.01M
Capital stock 0.01M 0.01M 0.00M 4.50M 0.01M
Retained earnings -454.41M -439.49M -428.28M -405.73M -384.53M
Good will 1.57M 0.00M - - -
Other assets - 0.00M - - -
Cash 3.50M 3.14M 3.38M 18.34M 36.56M
Total current liabilities 1.33M 6.27M 8.16M 7.51M 5.41M
Net debt -3.50M -3.14M -3.34M -18.24M -36.53M
Short long term debt total 0.00M - 0.04M 0.11M 0.03M
Other stockholder equity 461.29M 438.20M 429.80M 422.98M 422.96M
Total current assets 6.26M 3.67M 7.44M 24.41M 40.94M
Net receivables 1.26M 0.24M 3.73M 5.64M 4.30M
Inventory 1.38M 0.00M - - -
Accounts payable 0.62M 4.60M 3.54M 2.56M 2.12M
Accumulated other comprehensive income -0.04M -0.89M -0.91M -1.32M -0.75M
Non currrent assets other 0.21M 0.41M 1.26M 3.46M 2.10M
Non current assets total 1.93M 0.42M 1.36M 3.64M 2.19M
Capital lease obligations 0.00M 0.00M 0.04M 0.11M 0.03M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M -0.01M -0.01M -0.03M
Total cashflows from investing activities - - -0.01M -0.01M -0.03M
Total cash from financing activities 5.26M 7.82M 0.85M 3.00M 21.74M
Net income -3.00M -11.21M -22.55M -21.20M -18.46M
Change in cash 0.37M -0.24M -14.97M -18.21M 3.15M
Begin period cash flow 3.14M 3.38M 18.34M 36.56M 33.41M
End period cash flow 3.50M 3.14M 3.38M 18.34M 36.56M
Total cash from operating activities -4.77M -7.99M -16.11M -20.83M -18.54M
Issuance of capital stock 6.42M 6.21M 1.05M 3.20M 17.37M
Depreciation 0.01M 0.01M 0.03M 0.03M 0.04M
Dividends paid 0.06M 0.00M 0.20M 0.20M 0.20M
Change to inventory -1.38M 0.00M - - -
Change to account receivables -1.26M 0.00M - - -
Other cashflows from financing activities -1.10M 1.61M - - 4.57M
Capital expenditures 0.00M 0.00M 0.01M 0.01M 0.03M
Change in working capital -9.06M 2.62M 4.94M -1.17M -1.28M
Stock based compensation 2.33M 0.59M 1.47M 1.51M 1.16M
Other non cash items 4.95M -0.04M -0.07M - -
Free cash flow -4.77M -7.99M -16.12M -20.83M -18.57M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BGMS
Bio Green Med Solution, Inc.		 0.04
5.94%		 0.71 - - 8.76 0.96 4.07 0.02
NVO
Novo Nordisk A/S		 -0.54
1.32%		 40.55 41.58 31.15 2.13 32.99 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 -2.37
0.43%		 544.66 30.22 24.27 10.36 6.50 9.99 24.66
REGN
Regeneron Pharmaceuticals Inc		 -2.77
0.29%		 956.64 29.07 20.12 7.57 3.82 6.95 19.42
ARGNF
argenx SE		 -
-%		 900.30 45.77 31.25 13.84 7.12 11.38 36.06

Profile*

Bio Green Med Solution, Inc.

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Level 10, Kuala Lumpur, Malaysia, 592000

60 9 08517 7330

https://bgmsglobal.com

Name Title Year Born
Dr. Sing Ee Wong Chairman, CEO & President 1981
Mr. Cu Seng Kiu Executive Director, CFO & Secretary 1990
Ms. Gill Christie Director of Human Resources 1957
Grace Kim Investor Relations Executive NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…